PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Radiation Oncology, University Hospital Muenster, Albert-Schweitzer-Campus 1 building A1, 48149, Muenster, Germany.\', \'Department of Radiotherapy and Radiation Oncology, University Hospital Giessen-Marburg, Marburg, Germany.\', \'Department of Radiation Oncology and Cyberknife Center, University Hospital of Cologne, Cologne, Germany.\', \'Department of Radiotherapy and Radiation Oncology, University Hospital Mainz, Mainz, Germany.\', \'Department of Radiation Oncology, University Hospital Halle (Saale), Halle (Saale), Germany.\', \'Department of Radiooncology, Medical University Innsbruck, Innsbruck, Austria.\', \'Department of Radiation Oncology, Saarland University Hospital, Homburg, Germany.\', \'Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.\', \'Department of Medicine A, Hematology, Oncology, University Hospital Muenster, Muenster, Germany.\', \'Department of Radiation Oncology, University Hospital Muenster, Albert-Schweitzer-Campus 1 building A1, 48149, Muenster, Germany. hans.eich@ukmuenster.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00066-020-01705-w
?:hasPublicationType
?:journal
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
is ?:pmid of
?:pmid
?:pmid
  • 33125504
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic : Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all